Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Rubinstein

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Blood|July 7, 2012
Soluble IL-15/IL-15Rα complexes in human serumDavid J Cole, Mark P Rubinstein
Experimental Hematology & Oncology|December 12, 2013
Cancer immunotherapy: are we there yet?Zihai Li, Lieping Chen, Mark P Rubinstein
Cancer Discovery|May 2, 2022
Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer ImmunotherapyZihai Li, Joseph H Azar, Mark P Rubinstein
Seminars in Immunology|March 10, 2009
Surviving the crash: transitioning from effector to memory CD8+ T cellLouise M D'Cruz, Mark P Rubinstein, Ananda W Goldrath
Science (New York, N.Y.)|February 18, 2006
Selective stimulation of T cell subsets with antibody-cytokine immune complexesOnur Boyman, Marek Kovar, Mark P Rubinstein, et al.
Plos One|September 12, 2022
Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer modelHarinarayanan Janakiraman, Scott A Becker, Alexandra Bradshaw, et al.
Frontiers in Immunology|February 23, 2024
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19Bindu Adhikari, Joseph S Bednash, Jeffrey C Horowitz, et al.
Frontiers in Immunology|March 14, 2024
Corrigendum: Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19Bindu Adhikari, Joseph S Bednash, Jeffrey C Horowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2010
Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexesKutlu G Elpek, Mark P Rubinstein, Angelique Bellemare-Pelletier, et al.
Oncology Reviews|August 29, 2019
Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapyJacob S Bowers, Stefanie R Bailey, Mark P Rubinstein, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Blood|July 7, 2012
Soluble IL-15/IL-15Rα complexes in human serumDavid J Cole, Mark P Rubinstein
Experimental Hematology & Oncology|December 12, 2013
Cancer immunotherapy: are we there yet?Zihai Li, Lieping Chen, Mark P Rubinstein
Cancer Discovery|May 2, 2022
Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer ImmunotherapyZihai Li, Joseph H Azar, Mark P Rubinstein
Seminars in Immunology|March 10, 2009
Surviving the crash: transitioning from effector to memory CD8+ T cellLouise M D'Cruz, Mark P Rubinstein, Ananda W Goldrath
Science (New York, N.Y.)|February 18, 2006
Selective stimulation of T cell subsets with antibody-cytokine immune complexesOnur Boyman, Marek Kovar, Mark P Rubinstein, et al.
Plos One|September 12, 2022
Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer modelHarinarayanan Janakiraman, Scott A Becker, Alexandra Bradshaw, et al.
Frontiers in Immunology|February 23, 2024
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19Bindu Adhikari, Joseph S Bednash, Jeffrey C Horowitz, et al.
Frontiers in Immunology|March 14, 2024
Corrigendum: Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19Bindu Adhikari, Joseph S Bednash, Jeffrey C Horowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2010
Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexesKutlu G Elpek, Mark P Rubinstein, Angelique Bellemare-Pelletier, et al.
Oncology Reviews|August 29, 2019
Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapyJacob S Bowers, Stefanie R Bailey, Mark P Rubinstein, et al.
Pageof 8